Regencell Bioscience (RGC) Stock Drops in Thin Post‑Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center
Regencell Bioscience Holdings (RGC) fell about 13.5% to $21.28 in late morning trading Friday, with a wide intraday range and light volume. The drop came as major indexes held steady in subdued post-holiday trade. RGC’s volatility follows a year marked by a 38-for-1 stock split and insider control of nearly 89% of shares, leaving the float thin and price swings frequent.